The discovery, by researchers from Beth Israel Deaconess Medical Center, Harvard Medical School, Hebrew University and Duke University, has potentially crucial repercussions for the design of future vaccines, HIV in particular.
Click "source" for entire article.
"Thy1+ Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes" (http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1002141)


